Literature DB >> 27133464

Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

A Vanessa Stempel1, Alexander Stumpf2, Hai-Ying Zhang3, Tuğba Özdoğan2, Ulrike Pannasch2, Anne-Kathrin Theis2, David-Marian Otte4, Alexandra Wojtalla4, Ildikó Rácz4, Alexey Ponomarenko5, Zheng-Xiong Xi3, Andreas Zimmer4, Dietmar Schmitz6.   

Abstract

Endocannabinoids (eCBs) exert major control over neuronal activity by activating cannabinoid receptors (CBRs). The functionality of the eCB system is primarily ascribed to the well-documented retrograde activation of presynaptic CB1Rs. We find that action potential-driven eCB release leads to a long-lasting membrane potential hyperpolarization in hippocampal principal cells that is independent of CB1Rs. The hyperpolarization, which is specific to CA3 and CA2 pyramidal cells (PCs), depends on the activation of neuronal CB2Rs, as shown by a combined pharmacogenetic and immunohistochemical approach. Upon activation, they modulate the activity of the sodium-bicarbonate co-transporter, leading to a hyperpolarization of the neuron. CB2R activation occurred in a purely self-regulatory manner, robustly altered the input/output function of CA3 PCs, and modulated gamma oscillations in vivo. To conclude, we describe a cell type-specific plasticity mechanism in the hippocampus that provides evidence for the neuronal expression of CB2Rs and emphasizes their importance in basic neuronal transmission.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27133464      PMCID: PMC5533103          DOI: 10.1016/j.neuron.2016.03.034

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  78 in total

1.  Interference of biocytin with opioid-evoked hyperpolarization and membrane properties of rat spinal substantia gelatinosa neurons.

Authors:  W A Eckert; H H Willcockson; A R Light
Journal:  Neurosci Lett       Date:  2001-01-12       Impact factor: 3.046

2.  Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels.

Authors:  B Y Ho; Y Uezono; S Takada; I Takase; F Izumi
Journal:  Receptors Channels       Date:  1999

3.  Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids.

Authors:  Alberto Bacci; John R Huguenard; David A Prince
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

4.  Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.

Authors:  Q-R Liu; C-H Pan; A Hishimoto; C-Y Li; Z-X Xi; A Llorente-Berzal; M-P Viveros; H Ishiguro; T Arinami; E S Onaivi; G R Uhl
Journal:  Genes Brain Behav       Date:  2009-06-03       Impact factor: 3.449

Review 5.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

6.  Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels.

Authors:  Imke Jenniches; Svenja Ternes; Onder Albayram; David M Otte; Karsten Bach; Laura Bindila; Kerstin Michel; Beat Lutz; Andras Bilkei-Gorzo; Andreas Zimmer
Journal:  Biol Psychiatry       Date:  2015-04-14       Impact factor: 13.382

7.  Postsynaptic endocannabinoid release is critical to long-term depression in the striatum.

Authors:  G L Gerdeman; J Ronesi; D M Lovinger
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

8.  Persistent receptor activity underlies group I mGluR-mediated cellular plasticity in CA3 neuron.

Authors:  Steven R Young; Shih-Chieh Chuang; Wangfa Zhao; Robert K S Wong; Riccardo Bianchi
Journal:  J Neurosci       Date:  2013-02-06       Impact factor: 6.167

9.  Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice.

Authors:  Zheng-Xiong Xi; Xiao-Qing Peng; Xia Li; Rui Song; Hai-Ying Zhang; Qing-Rong Liu; Hong-Ju Yang; Guo-Hua Bi; Jie Li; Eliot L Gardner
Journal:  Nat Neurosci       Date:  2011-07-24       Impact factor: 24.884

10.  Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS.

Authors:  E S Onaivi
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

View more
  97 in total

1.  Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents.

Authors:  Chloe J Jordan; Zhi-Wei Feng; Ewa Galaj; Guo-Hua Bi; Ying Xue; Ying Liang; Terence McGuire; Xiang-Qun Xie; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

2.  Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.

Authors:  Ana Canseco-Alba; Norman Schanz; Branden Sanabria; Juan Zhao; Zhicheng Lin; Qing-Rong Liu; Emmanuel S Onaivi
Journal:  Behav Brain Res       Date:  2018-11-30       Impact factor: 3.332

Review 3.  Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling.

Authors:  Yuki Sugaya; Masanobu Kano
Journal:  Cell Mol Life Sci       Date:  2018-05-08       Impact factor: 9.261

4.  Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling.

Authors:  Stephanie C Gantz; Bruce P Bean
Journal:  Neuron       Date:  2017-03-02       Impact factor: 17.173

5.  Intracellular GPCRs Play Key Roles in Synaptic Plasticity.

Authors:  Yuh-Jiin I Jong; Steven K Harmon; Karen L O'Malley
Journal:  ACS Chem Neurosci       Date:  2018-02-16       Impact factor: 4.418

Review 6.  Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Authors:  Evan C Rosenberg; Pabitra H Patra; Benjamin J Whalley
Journal:  Epilepsy Behav       Date:  2017-02-09       Impact factor: 2.937

Review 7.  An overview of the cannabinoid type 2 receptor system and its therapeutic potential.

Authors:  Bihua Bie; Jiang Wu; Joseph F Foss; Mohamed Naguib
Journal:  Curr Opin Anaesthesiol       Date:  2018-08       Impact factor: 2.706

8.  Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.

Authors:  Jian Zhang; Chu Chen
Journal:  Mol Neurobiol       Date:  2017-07-21       Impact factor: 5.590

9.  Crystal Structure of the Human Cannabinoid Receptor CB2.

Authors:  Xiaoting Li; Tian Hua; Kiran Vemuri; Jo-Hao Ho; Yiran Wu; Lijie Wu; Petr Popov; Othman Benchama; Nikolai Zvonok; K'ara Locke; Lu Qu; Gye Won Han; Malliga R Iyer; Resat Cinar; Nathan J Coffey; Jingjing Wang; Meng Wu; Vsevolod Katritch; Suwen Zhao; George Kunos; Laura M Bohn; Alexandros Makriyannis; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

Review 10.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.